Tag Archives: Fusion Inhibitors Market

The market for fusion inhibitors is anticipated to expand at a CAGR of 14.7%, during the forecast period of 2024 and 2032, propelled by developments in antiviral therapies, the continued prevalence of HIV/AIDS, and the emerging role of fusion inhibitors in the treatment of COVID-19. Although the market faces a challenge due to the limited route of administration options, it ...